News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
03-May-2012 - Genzyme, a Sanofi company, announced that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved a second suite for filling and finishing product at its Waterford, Ireland manufacturing plant. With this approval, Genzyme has nearly doubled its ability to ...
07-Feb-2011 - Amarin Corporation plc announced that Paul E. Huff has joined the Company as Chief Commercial Officer. In this role, Mr. Huff is responsible for driving Amarin’s AMR101 commercialization strategy, including all marketing and sales planning and implementation, including product launch activities. ...
11-Aug-2010 - Amarin Corporation plc announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial. The Company indicated that top line results from this trial are expected early in 2011, towards the early part of ...
16-Feb-2010 - Amarin Corporation plc announced the appointment of Mr. Jan van Heek to its board of directors as a non-executive director. As part of his board role, Mr. van Heek has been appointed Chairman of the Company’s Audit Committee. Mr. van Heek (age 60) brings significant international business ...
12-Jun-2009 - Research and Markets has announced the addition of Decision Resources, Inc.'s new report "Riding the Biotech Economic Tsunami - Surfing to Safety or Wipeout?" to their offering. In 2008, the global financial crisis radically altered the dynamics of the biotech industry; many weaker companies ...
06-Oct-2008 - Shire Limited announces that following the approval by shareholders at the Annual General Meeting on September 24, 2008, the Company has changed its name to Shire plc with effect from today. Shire plc's ticker symbols on the London Stock Exchange and NASDAQ and the ISIN numbers of the Company's ...
08-Sep-2008 - Elan Corporation, plc and Biogen Idec announced the initiation of the first clinical trial of TYSABRI® (natalizumab) in oncology. The first dose of TYSABRI was administered in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of ...
© 1997-2024 LUMITOS AG, All rights reserved